Flamel Technologies is a drug delivery company focused on improving existing compounds using its Medusa and Micropump drug delivery technologies. The company entered into collaboration with Merck Serono in December 2007, to investigate the applicability of Flamel Technologies’ Medusa technology for the extended release of a therapeutic protein of Merck Serono’s portfolio.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis
Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors
Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
Flamel Technologies’ Medusa platform product pipeline includes: IFN alpha-2b XL (Interferon alpha-2b XL) for hepatitis (Phase II), FT-105 for the treatment of type II diabetes (Phase I), IL-2 XL for the treatment of late stage renal cancer or metastatic melanoma (Phase I) and HGH XL used for the treatment of growth disorders (Preclinical).Flamel Technologies derives its revenues from the product sales of Coreg CR microparticles to GSK; and research and development, and license revenues from various pharmaceutical companies such as GSK and other undisclosed partners.Flamel Technologies’s total revenues are expected to increase from $23 million in 2006 to $124 million in 2010. The company’s major contributor to sales growth out to 2010 will be the royalties from GSK related to the product sales of Coreg CR which was approved in October 2006, for the treatment of cardiovascular diseases
Reasons to Purchase
Access all the important information and analysis on the company in a single report
Understand company’s strengths, weaknesses, opportunities and threats along with business strategy and value chain
Gain access to company’s adjusted five year financial data along with key ratios and market capitalization
TABLE OF CONTENTS
Overview 1 Catalyst 1 Summary 1 Company Structure 7 Company Overview and Key Facts 7 Business Description 8 History 9 Locations and Subsidiaries 11 Company Financials 12 Stock Market Performance 12 P&L 13 Balance Sheet 16 Cash Flow 16 Business Segment Performance 17 Geographic Segment Performance 19 Products & Services 20 Pipeline Products 20 AC Forecast Product Sales 22 Competitors and Strategic Business Relationships 23 Top Competitors 23 Key Clients 23 Shareholding Structure 24 Strategy 25 Company View 25 Corporate Strategy 28 SWOT Analysis 30 Overview 30 Strengths 31 Weaknesses 32 Opportunities 33 Threats 34 Value Chain Analysis 35 Overview 35 Product Development 36 Manufacturing 36 Sales 36 Scorecard 37 Overview 37 Scorecard Analysis 38 Key Employees 39 List of Key Employees 39 Key Employee Biographies 40 Financial and Operational Overview 44 Financial and Operational Overview 44 Appendix 46 Ask the analyst 46 Datamonitor consulting 46 Disclaimer 46
